Gleason Group, Inc. Viatris Inc Transaction History
Gleason Group, Inc.
- $492 Million
- Q2 2024
A detailed history of Gleason Group, Inc. transactions in Viatris Inc stock. As of the latest transaction made, Gleason Group, Inc. holds 830 shares of VTRS stock, worth $9,677. This represents 0.0% of its overall portfolio holdings.
Number of Shares
830
Previous 51
1527.45%
Holding current value
$9,677
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding VTRS
# of Institutions
1,098Shares Held
970MCall Options Held
2.63MPut Options Held
2.15M-
Vanguard Group Inc Valley Forge, PA140MShares$1.64 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.08 Billion0.02% of portfolio
-
State Street Corp Boston, MA62.1MShares$724 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az57.5MShares$671 Million3.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD56.8MShares$663 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $14.1B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...